^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Serine protease inhibitor

    Related drugs:
    6d
    IVTXA: Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy (clinicaltrials.gov)
    P2, N=150, Recruiting, University of California, San Francisco | Trial completion date: May 2026 --> May 2032 | Trial primary completion date: May 2026 --> May 2032
    Trial completion date • Trial primary completion date
    6d
    EFFECT OF TRANEXAMIC ACID ON PERIOPERATIVE BLOOD LOSS IN REAMED INTRAMEDULLARY NAILING OF DIAPHYSEAL FEMORAL AND TIBIAL FRACTURES: A PROSPECTIVE COMPARATIVE STUDY (clinicaltrials.gov)
    P=N/A, N=54, Completed, Kathmandu University School of Medical Sciences
    New trial
    13d
    Combined Tranexamic Acid Use in Total Hip Replacement Surgery (clinicaltrials.gov)
    P=N/A, N=58, Completed, St. Anne's University Hospital Brno, Czech Republic
    New trial
    15d
    TEAPOT Study Multisite (clinicaltrials.gov)
    P1, N=30, Not yet recruiting, The University of Texas Health Science Center at San Antonio | Initiation date: Apr 2026 --> Jul 2026
    Trial initiation date
    15d
    Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102) (clinicaltrials.gov)
    P1, N=54, Recruiting, Ensysce Biosciences | N=30 --> 54 | Trial completion date: Dec 2026 --> Apr 2027 | Trial primary completion date: Jul 2026 --> Dec 2026
    Enrollment change • Trial completion date • Trial primary completion date
    29d
    Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery (clinicaltrials.gov)
    P=N/A, N=90, Not yet recruiting, Poznan University of Medical Sciences
    New trial
    1m
    Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis (clinicaltrials.gov)
    P1, N=60, Recruiting, Vanderbilt University Medical Center | Trial completion date: Feb 2026 --> Apr 2029 | Trial primary completion date: Feb 2026 --> Apr 2029
    Trial completion date • Trial primary completion date
    1m
    TEAPOT Study Multisite (clinicaltrials.gov)
    P1, N=30, Not yet recruiting, The University of Texas Health Science Center at San Antonio
    New P1 trial
    1m
    CamKid: Effect Camostat for Kidney Protection in Chronic Kidney Disease (clinicaltrials.gov)
    P2, N=40, Recruiting, Odense University Hospital | Completed --> Recruiting
    Enrollment open
    1m
    Tranexamic Acid in Adult Spinal Deformity Surgery (clinicaltrials.gov)
    P3, N=100, Recruiting, Hospital for Special Surgery, New York | Trial completion date: Mar 2026 --> Mar 2027 | Trial primary completion date: Mar 2026 --> Mar 2027
    Trial completion date • Trial primary completion date
    2ms
    TEAPOT: TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study (clinicaltrials.gov)
    P1, N=12, Recruiting, The University of Texas Health Science Center at San Antonio | Not yet recruiting --> Recruiting
    Enrollment open
    2ms
    Comparison of Anticoagulant Efficacy of Different Doses of Nafamostat Mesylate in Continuous Renal Replacement Therapy (CRRT) in the ICU (ChiCTR2600121852)
    P=N/A, N=92, Zhujiang Hospital of Southern Medical University; Zhujiang Hospital of Southern Medical University
    New trial
    |
    nafamostat